Cited by 599Cystic Fibrosis Research AdvancesBacterial biofilms and quorum sensingMicrobial Community Ecology and Physiology

The DOI matches its Crossref record; 17 of the 18 references it cites were found in a registry or an index.

Decade-long bacterial community dynamics in cystic fibrosis airways

Open access

Zhao, Jiangchao, Schloss, Patrick D., Kalikin, Linda M., Carmody, Lisa A., Foster, Bridget K., Petrosino, Joseph F., Cavalcoli, James D., VanDevanter, Donald R., Murray, Susan, Li, Jun Z., Young, Vincent B., LiPuma, John J.·2012·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.1120577109PMC PMC3326496

Open this paper in CoChat — free account

Abstract

The structure and dynamics of bacterial communities in the airways of persons with cystic fibrosis (CF) remain largely unknown. We characterized the bacterial communities in 126 sputum samples representing serial collections spanning 8-9 y from six age-matched male CF patients. Sputum DNA was analyzed by bar-coded pyrosequencing of the V3-V5 hypervariable region of the 16S rRNA gene, defining 662 operational taxonomic units (OTUs) from >633,000 sequences. Bacterial community diversity decreased significantly over time in patients with typically progressive lung disease but remained relatively stable in patients with a mild lung disease phenotype. Antibiotic use, rather than patient age or lung function, was the primary driver of decreasing diversity. Interpatient variability in community structure exceeded intrapatient variability in serial samples. Antibiotic treatment was associated with pronounced shifts in community structure, but communities showed both short- and long-term resilience after antibiotic perturbation. There was a positive correlation between OTU occurrence and relative abundance, with a small number of persistent OTUs accounting for the greatest abundance. Significant changes in community structure, diversity, or total bacterial density at the time of pulmonary exacerbation were not observed. Despite decreasing community diversity in patients with progressive disease, total bacterial density remained relatively stable over time. These findings show the critical relationship between airway bacterial community structure, disease stage, and clinical state at the time of sample collection. These features are the key parameters with which to assess the complex ecology of the CF airway.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1073/pnas.1120577109

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial Communities
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549
Self-citation
A new method for non-parametric multivariate analysis of variance
Anderson, M. J. (2001) · Austral Ecology · doi:10.1111/j.1442-9993.2001.01070.pp.x · Cited by 13,828
Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set
Nadkarni, M. A., Martin, F. E., Jacques, N. A., & Hunter, N. (2002) · Microbiology · doi:10.1099/00221287-148-1-257 · Cited by 1,931
Detection of Anaerobic Bacteria in High Numbers in Sputum from Patients with Cystic Fibrosis
Tunney, M. M., Field, T. R., Moriarty, T. F., Patrick, S., Doering, G., Muhlebach, M. S., Wolfgang, M. C., Boucher, R. C., Gilpin, D. F., McDowell, A., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200708-1151oc · Cited by 466
Airway Microbiota and Pathogen Abundance in Age-Stratified Cystic Fibrosis Patients
Cox, M. J., Allgaier, M., Taylor, B., Baek, M. S., Huang, Y. J., Daly, R. A., Karaöz, U., Andersen, G. L., Brown, R., Fujimura, K. E., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011044 · Cited by 458
Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis
Harris, J. K., Groote, M. A. D., Sagel, S. D., Zemanick, E. T., Kapsner, R. K., Penvari, C., Kaess, H., Deterding, R. R., Accurso, F. J., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709804104 · Cited by 373
Characterization of Bacterial Community Diversity in Cystic Fibrosis Lung Infections by Use of 16S Ribosomal DNA Terminal Restriction Fragment Length Polymorphism Profiling
Rogers, G. B., Carroll, M. P., Serisier, D. J., Hockey, P., Jones, G., & Bruce, K. D. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.11.5176-5183.2004 · Cited by 316
A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients
Sibley, C. D., Parkins, M. D., Rabin, H. R., Duan, K., Nørgaard, J. C., & Surette, M. G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804326105 · Cited by 311
Partitioning core and satellite taxa from within cystic fibrosis lung bacterial communities
Gast, C., Walker, A. W., Stressmann, F. A., Rogers, G. B., Scott, P., Daniels, T. W. V., Carroll, M. P., Parkhill, J., & Bruce, K. D. (2010) · The ISME Journal · doi:10.1038/ismej.2010.175 · Cited by 265
Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa
Klepac‐Ceraj, V., Lemon, K. P., Martin, T. R., Allgaier, M., Kembel, S. W., Knapp, A. A., Lory, S., Brodie, E., Lynch, S. V., Bohannan, B. J. M., et al. (2010) · Environmental Microbiology · doi:10.1111/j.1462-2920.2010.02173.x · Cited by 219

Show all 18 references

Sorted by citations

Items 301–400 of 594

Changing profile of bacterial infection and microbiome in cystic fibrosis: when to use antibiotics in the era of CFTR-modulator therapy
Milczewska, J., Syunyaeva, Z., Żabińska-Jaroń, A., Sands, D., & Thee, S. A. (2024) · European Respiratory Review · doi:10.1183/16000617.0068-2024 · Cited by 26
Lung Microbiome in Cystic Fibrosis
Scialò, F., Amato, F., Cernera, G., Gelzo, M., Zarrilli, F., Comegna, M., Pastore, L., Bianco, A., & Castaldo, G. (2021) · Life · doi:10.3390/life11020094 · Cited by 28
Nebulized liposomal amikacin for the treatment of Pseudomonas aeruginosa infection in cystic fibrosis patients
Ehsan, Z., Wetzel, J. D., & Clancy, J. P. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.895322 · Cited by 26
Differential Responses to Rhinovirus- and Influenza-associated Pulmonary Exacerbations in Patients with Cystic Fibrosis
Ramirez, I. A., Caverly, L. J., Kalikin, L. M., Goldsmith, A. M., Lewis, T. C., Burke, D., LiPuma, J. J., Sajjan, U. S., & Hershenson, M. B. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201310-346oc · Cited by 26
Self-citation
In vitro activity of colistin against biofilm by Pseudomonas aeruginosa is significantly improved under “cystic fibrosis–like” physicochemical conditions
Pompilio, A., Crocetta, V., Pomponio, S., Fiscarelli, E. V., & Bonaventura, G. D. (2015) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2015.01.006 · Cited by 26
Effects of Propidium Monoazide (PMA) Treatment on Mycobiome and Bacteriome Analysis of Cystic Fibrosis Airways during Exacerbation
Nguyen, L. D. N., Deschaght, P., Merlin, S., Loywick, A., Audebert, C., daele, S. V., Viscogliosi, É., Vaneechoutte, M., & Delhaès, L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168860 · Cited by 28
2,3‐Butanediol catabolism in Pseudomonas aeruginosa PAO1
Liu, Q., Liu, Y., Kang, Z., Xiao, D., Gao, C., Xu, P., & Ma, C. (2018) · Environmental Microbiology · doi:10.1111/1462-2920.14332 · Cited by 26
Anaerobes in cystic fibrosis patients’ airways
Lamoureux, C., Guilloux, C.-A., Beauruelle, C., Jolivet‐Gougeon, A., & Héry-Arnaud, G. (2019) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2018.1549019 · Cited by 32
Cystic Fibrosis Patients Infected With Epidemic Pseudomonas aeruginosa Strains Have Unique Microbial Communities
Acosta, N., Waddell, B. J. M., Heirali, A., Somayaji, R., Surette, M. G., Workentine, M. L., Rabin, H. R., & Parkins, M. D. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00173 · Cited by 26
The Lung Microbiome in Young Children with Cystic Fibrosis: A Prospective Cohort Study
Linnane, B. M., Walsh, A. M., Walsh, C. J., Crispie, F., O’Sullivan, Ó., Cotter, P. D., McDermott, M., Renwick, J. A. A., & McNally, P. (2021) · Microorganisms · doi:10.3390/microorganisms9030492 · Cited by 25
Resistance evolution can disrupt antibiotic exposure protection through competitive exclusion of the protective species
Quinn, A., Bottery, M. J., Thompson, H., & Friman, V. (2022) · The ISME Journal · doi:10.1038/s41396-022-01285-w · Cited by 25
The respiratory microbiome of HIV-infected individuals
Lawani, M. B., & Morris, A. (2016) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2016.1206469 · Cited by 26
Profiling of Bacterial and Fungal Microbial Communities in Cystic Fibrosis Sputum Using RNA
Grahl, N., Dolben, E. L., Filkins, L., Crocker, A. W., Willger, S. D., Morrison, H. G., Sogin, M. L., Ashare, A., Gifford, A. H., Jacobs, N. J., et al. (2018) · mSphere · doi:10.1128/msphere.00292-18 · Cited by 25
Mild Cystic Fibrosis Lung Disease Is Associated with Bacterial Community Stability
Hampton, T. H., Thomas, D., Gast, C., O’Toole, G. A., & Stanton, B. A. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00029-21 · Cited by 25
Microbial community organization designates distinct pulmonary exacerbation types and predicts treatment outcome in cystic fibrosis
Stefanie Widder, A., Carmody, L. A., Opron, K., Kalikin, L. M., Caverly, L. J., & LiPuma, J. J. (2024) · Nature Communications · doi:10.1038/s41467-024-49150-y · Cited by 24
Self-citation
Clinical outcomes associated with Achromobacter species infection in people with cystic fibrosis
Kerem, E., Orenti, A., Zolin, A., Annicchiarico, L., & Dřevı́nek, P. (2022) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2022.11.001 · Cited by 24
Cell free DNA from respiratory pathogens is detectable in the blood plasma of Cystic Fibrosis patients
Barrett, S. L. R., Holmes, E. A., Long, D. R., Shean, R. C., Bautista, G. E., Ravishankar, S., Peddu, V., Cookson, B. T., Singh, P. K., Greninger, A. L., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-63970-0 · Cited by 25
Practical Guidance for Clinical Microbiology Laboratories: Updated guidance for processing respiratory tract samples from people with cystic fibrosis
Saiman, L. M., Waters, V. J., LiPuma, J. J., Hoffman, L. R., Alby, K., Zhang, S. X., Yau, Y. C. W., Downey, D. G., Sermet‐Gaudelus, I., Bouchara, J.-P., et al. (2024) · Clinical Microbiology Reviews · doi:10.1128/cmr.00215-21 · Cited by 23
Self-citation
Cystic fibrosis airway microbiota associated with outcomes of nontuberculous mycobacterial infection
Caverly, L. J., Zimbric, M., Azar, M., Opron, K., & LiPuma, J. J. (2021) · ERJ Open Research · doi:10.1183/23120541.00578-2020 · Cited by 23
Self-citation
Antibiotics Drive Expansion of Rare Pathogens in a Chronic Infection Microbiome Model
Varga, J. J., Zhao, C., Davis, J. D., Hao, Y., Farrell, J. M., Gurney, J., Voit, E. O., & Brown, S. P. (2022) · mSphere · doi:10.1128/msphere.00318-22 · Cited by 23
The impact of environmental factors on respiratory tract microbiome and respiratory system diseases
Ge, Y. C., Tang, G., Fu, Y., Deng, P., & Yao, R. (2025) · European journal of medical research · doi:10.1186/s40001-025-02517-3 · Cited by 22
JTD special edition 'Hot Topics in COPD'-The microbiome in COPD.
Chambers, D. C., Gellatly, S. L., Hugenholtz, P., & Hansbro, P. M. (2014) · PubMed Central · doi:10.3978/j.issn.2072-1439.2014.11.08 · Cited by 22
Bacterial Culture Underestimates Lung Pathogen Detection and Infection Status in Cystic Fibrosis
Gavillet, H., Hatfield, L. R., Rivett, D. W., Jones, A. M., Maitra, A., Horsley, A. R., & Gast, C. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00419-22 · Cited by 22
Antisense Inhibitors Retain Activity in Pulmonary Models of Burkholderia Infection
Daly, S. M., Sturge, C. R., Marshall‐Batty, K. R., Felder-Scott, C. F., Jain, R., Geller, B. L., & Greenberg, D. E. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00235 · Cited by 22
Strain-Resolved Dynamics of the Lung Microbiome in Patients with Cystic Fibrosis
Dmitrijeva, M., Kahlert, C. R., Feigelman, R., Kleiner, R. L., Nolte, O., Albrich, W. C., Baty, F., & von Mering, C. (2021) · mBio · doi:10.1128/mbio.02863-20 · Cited by 22
Changes in microbiome diversity following beta-lactam antibiotic treatment are associated with therapeutic versus subtherapeutic antibiotic exposure in cystic fibrosis
Hahn, A., Fanous, H., Jensen, C. D., Chaney, H. R., Sami, I. R., Pérez, G. F., Koumbourlis, A. C., Louie, S. G., Bost, J. E., van den Anker, J. N., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-38984-y · Cited by 22
Inhalation exposure to chemicals, microbiota dysbiosis and adverse effects on humans
Utembe, W., & Kamng’ona, A. W. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.176938 · Cited by 21
Positioning the preventive potential of microbiome treatments for cystic fibrosis in the context of current therapies
Cauwenberghs, E., Boeck, I. D., Spacova, I., Tente, I. V., Bastiaenssen, J., Lammertyn, E. J., Verhulst, S. L., Hoorenbeeck, K. V., & Lebeer, S. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101371 · Cited by 22
A Continuous-Flow Model for in vitro Cultivation of Mixed Microbial Populations Associated With Cystic Fibrosis Airway Infections
O’Brien, T. J., & Welch, M. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02713 · Cited by 21
How to use: bacterial cultures in diagnosing lower respiratory tract infections in cystic fibrosis
Ahmed, B., Bush, A., & Davies, J. C. (2013) · Archives of Disease in Childhood Education & Practice · doi:10.1136/archdischild-2012-303408 · Cited by 21
The new microbiology of cystic fibrosis: it takes a community
LiPuma, J. J. (2012) · Thorax · doi:10.1136/thoraxjnl-2012-202018 · Cited by 21
Self-citation
Microbiota associations with inflammatory pathways in asthma
Wang, J., Chai, J., Zhang, L., Zhang, L., Yan, W., Sun, L., Chen, Y., Sun, Y., Zhao, J., & Chang, C. H. (2021) · Clinical & Experimental Allergy · doi:10.1111/cea.14089 · Cited by 20
Self-citation
Lung Microbiome in Human Health and Diseases
Chauhan, N. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00077-2 · Cited by 20
Pseudomonas aeruginosa surface motility and invasion into competing communities enhance interspecies antagonism
Peña, A. S., Winans, J. B., Nadell, C. D., & Limoli, D. H. (2024) · mBio · doi:10.1128/mbio.00956-24 · Cited by 20
Clinical Insights into Pulmonary Exacerbations in Cystic Fibrosis from the Microbiome. What Are We Missing?
Whelan, F., & Surette, M. G. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201506-353aw · Cited by 20
Activity of hypothiocyanite and lactoferrin (ALX-009) against respiratory cystic fibrosis pathogens in sputum
Tunney, M. M., Payne, J., McGrath, S., Einarsson, G. G., Ingram, R. J., Gilpin, D. F., Juarez-Perez, V., & Elborn, J. S. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky357 · Cited by 20
Airway microenvironment alterations and pathogen growth in cystic fibrosis
Rossi, G. A., Morelli, P., Galietta, L. J. V., & Colin, A. A. (2019) · Pediatric Pulmonology · doi:10.1002/ppul.24246 · Cited by 22
Assessment of stability and fluctuations of cultured lower airway bacterial communities in people with cystic fibrosis
Sherrard, L. J., Einarsson, G. G., Johnston, E., O’Neill, K., McIlreavey, L., McGrath, S., Gilpin, D. F., Downey, D. G., Reid, A. J. M., McElvaney, N. G., et al. (2019) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2019.02.012 · Cited by 20
Demographic, clinical, and laboratory parameters of cystic fibrosis during the last two decades: a comparative analysis
CYFIUC Group, Marson, F. A. L., Hortêncio, T. D. R., Aguiar, K. C. A., & Ribeiro, J. D. (2015) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-15-3 · Cited by 20
Engineering Human Microbiota: Influencing Cellular and Community Dynamics for Therapeutic Applications
Woloszynek, S., Pastor, S. J., Mell, J. C., Nandi, N., Sokhansanj, B. A., & ROSEN, G. L. (2016) · International review of cytology · doi:10.1016/bs.ircmb.2016.01.003 · Cited by 20
Microbiology of the Upper and Lower Airways in Pediatric Cystic Fibrosis Patients
Sobin, L. B., Kawai, K., Irace, A. L., Gergin, Ö., Cunningham, M. J., Sawicki, G. S., & Adil, E. A. (2017) · Otolaryngology · doi:10.1177/0194599817702332 · Cited by 19
Factoring in the Complexity of the Cystic Fibrosis Lung to Understand Aspergillus fumigatus and Pseudomonas aeruginosa Interactions
Beswick, E., Amich, J., & Gago, S. (2020) · Pathogens · doi:10.3390/pathogens9080639 · Cited by 19
Diversity of cystic fibrosis chronic rhinosinusitis microbiota correlates with different pathogen dominance
Lucas, S. K., Feddema, E., Boyer, H. C., & Hunter, R. C. (2021) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2021.03.022 · Cited by 19
Citizen-science based study of the oral microbiome in Cystic fibrosis and matched controls reveals major differences in diversity and abundance of bacterial and fungal species
Willis, J. R., Saus, E., Iraola‐Guzmán, S., Cabello-Yeves, E., Księżopolska, E., Cozzuto, L., Bejarano, L. A., Andreu, N., Alloza-Trabado, M., Blanco, A., et al. (2021) · Journal of Oral Microbiology · doi:10.1080/20002297.2021.1897328 · Cited by 19
Does Antibiotic Resistance Evolve in Hospitals?
Seigal, A., Mira, P., Sturmfels, B., & Barlow, M. (2017) · Bulletin of Mathematical Biology · doi:10.1007/s11538-016-0232-7 · Cited by 18
Surface growth of Pseudomonas aeruginosa reveals a regulatory effect of 3-oxo-C 12 -homoserine lactone in the absence of its cognate receptor, LasR
Pereira, T. D. O., Groleau, M., & Déziel, É. (2023) · mBio · doi:10.1128/mbio.00922-23 · Cited by 18
Airway microbial diversity is decreased in young children with cystic fibrosis compared to healthy controls but improved with CFTR modulation
Hahn, A., Burrell, A., Ansusinha, E., Peng, D., Chaney, H. R., Sami, I. R., Pérez, G. F., Koumbourlis, A. C., McCarter, R., Freishtat, R. J., et al. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e04104 · Cited by 18
Chlamydia pneumoniaeandMycoplasma pneumoniaein children with cystic fibrosis: impact on bacterial respiratory microbiota diversity
Pittet, L. F., Bertelli, C., Scherz, V., Rochat, I., Mardegan, C., Brouillet, R., Jaton, K., Mornand, A., Kaiser, L., Posfay-Barbe, K. M., et al. (2020) · Pathogens and Disease · doi:10.1093/femspd/ftaa074 · Cited by 18
Outdoor Atmospheric Microbial Diversity Is Associated With Urban Landscape Structure and Differs From Indoor-Transit Systems as Revealed by Mobile Monitoring and Three-Dimensional Spatial Analysis
Stewart, J. D., Kremer, P., Shakya, K. M., Conway, M., & Saad, A. (2021) · Frontiers in Ecology and Evolution · doi:10.3389/fevo.2021.620461 · Cited by 18
Inflammation in children with cystic fibrosis: contribution of bacterial production of long-chain fatty acids
Felton, E., Burrell, A., Chaney, H. R., Sami, I. R., Koumbourlis, A. C., Freishtat, R. J., Crandall, K. A., & Hahn, A. (2021) · Pediatric Research · doi:10.1038/s41390-021-01419-4 · Cited by 18
Is There a Role for Antimicrobial Stewardship in Cystic Fibrosis?
Waters, V. J., & Ratjen, F. A. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201401-034oi · Cited by 18
Respiratory Syncytial Virus Infection is Associated with Increased Bacterial Load in the Upper Respiratory Tract in Young Children
Chappell, K. J. (2013) · Journal of Medical Microbiology & Diagnosis · doi:10.4172/2161-0703.s1-005 · Cited by 19
Microbial Diversity in the Cystic Fibrosis Airways: Where is thy Sting?
VanDevanter, D. R., & LiPuma, J. J. (2012) · Future Microbiology · doi:10.2217/fmb.12.55 · Cited by 18
Self-citation
Long-term therapy with elexacaftor/tezacaftor/ivacaftor (ETI) in cystic fibrosis: improved clinical outcomes but infection and inflammation persist
Tunney, M. M., & Wark, P. A. B. (2023) · European Respiratory Journal · doi:10.1183/13993003.01008-2023 · Cited by 18
Availability of Zinc Impacts Interactions between Streptococcus sanguinis and Pseudomonas aeruginosa in Coculture
Li, K., Gifford, A. H., Hampton, T. H., & O’Toole, G. A. (2019) · Journal of Bacteriology · doi:10.1128/jb.00618-19 · Cited by 18
Porphyromonas pasteri and Prevotella nanceiensis in the sputum microbiota are associated with increased decline in lung function in individuals with cystic fibrosis
Webb, K., Zain, N. M. M., Stewart, I. D., Fogarty, A., Nash, E. F., Whitehouse, J. L., Smyth, A. R., Lilley, A. K., Knox, A. J., Williams, P. M., et al. (2022) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001481 · Cited by 17
Microbiome Data Enhances Predictive Models of Lung Function in People With Cystic Fibrosis
Zhao, C., Hao, Y., Wang, Y., Varga, J. J., Stecenko, A. A., Goldberg, J. B., & Brown, S. P. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa655 · Cited by 17
Commentary: Assessing Airway Microbiota in Cystic Fibrosis: What More Should Be Done?
LiPuma, J. J. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.01218-15 · Cited by 17
Self-citation
Mechanical Homogenization Increases Bacterial Homogeneity in Sputum
Stokell, J. R., Khan, A., & Steck, T. R. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.00487-14 · Cited by 16
Three Distinct Contact-Dependent Growth Inhibition Systems Mediate Interbacterial Competition by the Cystic Fibrosis Pathogen Burkholderia dolosa
Perault, A. I., & Cotter, P. A. (2018) · Journal of Bacteriology · doi:10.1128/jb.00428-18 · Cited by 16
Changes in Microbiome Dominance Are Associated With Declining Lung Function and Fluctuating Inflammation in People With Cystic Fibrosis
Frey, D. L., Bridson, C., Dittrich, S. A., Graeber, S. Y., Stahl, M., Wege, S., Herth, F. J. F., Sommerburg, O., Schultz, C., Dalpke, A. H., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.885822 · Cited by 16
Effects of Lumacaftor-Ivacaftor on Airway Microbiota-Mycobiota and Inflammation in Patients with Cystic Fibrosis Appear To Be Linked to Pseudomonas aeruginosa Chronic Colonization
Enaud, R., Lussac‐Sorton, F., Charpentier, É., Velo‐Suárez, L., Guiraud, J., Bui, S., Fayon, M. J., Schaeverbeke, T., Nikolski, M., the LumIvaBiota Study Group, et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.02251-22 · Cited by 16
Recapitulation of Polymicrobial Communities Associated with Cystic Fibrosis Airway Infections: A Perspective
O’Brien, T. J., & Welch, M. (2019) · Future Microbiology · doi:10.2217/fmb-2019-0200 · Cited by 16
Gastrointestinal consequences of lipopolysaccharide-induced lung inflammation
McQuade, R. M., Bandara, M., Diwakarla, S., Sahakian, L., Han, M. N., Thaalibi, M. A., Natale, M. R. D., Tan, M., Harwood, K. H., Schneider‐Futschik, E. K., et al. (2022) · Inflammation Research · doi:10.1007/s00011-022-01657-0 · Cited by 15
Exploring the Role of Gut-Lung Interactions in COPD Pathogenesis: A Comprehensive Review on Microbiota Characteristics and Inflammation Modulation
Cheng, Z.-X., & Zhang, J. (2024) · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · doi:10.15326/jcopdf.2023.0442 · Cited by 15
Methods for Extraction and Detection of Pf Bacteriophage DNA from the Sputum of Patients with Cystic Fibrosis
Burgener, E. B., Secor, P. R., Tracy, M. C., Sweere, J. M., Bik, E. M., Milla, C. E., & Bollyky, P. L. (2020) · PHAGE · doi:10.1089/phage.2020.0003 · Cited by 15
Systems Biology and Bile Acid Signalling in Microbiome-Host Interactions in the Cystic Fibrosis Lung
Woods, D. F., Flynn, S., Caparros-Martin, J. A., Stick, S. M., Reen, F. J., & O’Gara, F. (2021) · Antibiotics · doi:10.3390/antibiotics10070766 · Cited by 16
Severe Achromobacter xylosoxidans infection and loss of sputum bacterial diversity in an adult patient with cystic fibrosis
Talbot, N. P., & Flight, W. G. (2016) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2016.06.011 · Cited by 15
Type 1 diabetes: Through the lens of human genome and metagenome interplay
Vahed, S. Z., Sani, H. M., Saadat, Y. R., Barzegari, A., & Omidi, Y. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.05.052 · Cited by 15
Introduction to Techniques and Methodologies for Characterizing the Human Respiratory Virome
Mitchell, A. B., & Glanville, A. R. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8682-8_9 · Cited by 16
Detecting respiratory infection in children with cystic fibrosis: Cough swab, sputum induction or bronchoalveolar lavage
Forton, J. T. (2019) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2019.03.001 · Cited by 15
Intestinal Escherichia coli and related dysfunction as potential targets of Traditional Chinese Medicine for respiratory infectious diseases
Wei, L., Zhang, L., Zhang, Y., Yan, L., Liu, B., Cao, Z., Zhao, N., He, X., Li, L., & Lu, C. C. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116381 · Cited by 14
Effect of bovine respiratory disease on the respiratory microbiome: a meta-analysis
Howe, S. M., Kegley, E. B., Powell, J. G., Chen, S., & Zhao, J. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1223090 · Cited by 17
Self-citation
The gut-lung axis in the CFTR modulator era
Lussac‐Sorton, F., Charpentier, É., Imbert, S., Lefranc, M., Bui, S., Fayon, M. J., Berger, P., Enaud, R., & Delhaès, L. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1271117 · Cited by 14
Making It Last: Storage Time and Temperature Have Differential Impacts on Metabolite Profiles of Airway Samples from Cystic Fibrosis Patients
Wandro, S., Carmody, L. A., Gallagher, T. M., LiPuma, J. J., & Whiteson, K. (2017) · mSystems · doi:10.1128/msystems.00100-17 · Cited by 14
Self-citation
Agmatine accumulation by Pseudomonas aeruginosa clinical isolates confers antibiotic tolerance and dampens host inflammation
McCurtain, J. L., Gilbertsen, A. J., Evert, C., Williams, B. J., & Hunter, R. C. (2019) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000928 · Cited by 14
Liquid Chromatography Mass Spectrometry Detection of Antibiotic Agents in Sputum from Persons with Cystic Fibrosis
Gallagher, T. M., Riedel, S. F., Kapcia, J., Caverly, L. J., Carmody, L. A., Kalikin, L. M., Lu, J., Phan, J. L., Gargus, M. D., Kagawa, M., et al. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00927-20 · Cited by 14
Self-citation
Sputum Metabolites Associated with Nontuberculous Mycobacterial Infection in Cystic Fibrosis
Breen, P., Zimbric, M., Opron, K., & Caverly, L. J. (2022) · mSphere · doi:10.1128/msphere.00104-22 · Cited by 14
Use of denaturing high-performance liquid chromatography (DHPLC) to characterize the bacterial and fungal airway microbiota of cystic fibrosis patients
Mounier, J., Gouello, A., Keravec, M., Gal, S. L., Pacini, G., Debaets, S., Nevez, G., Rault, G., Barbier, G., & Héry-Arnaud, G. (2014) · The Journal of Microbiology · doi:10.1007/s12275-014-3425-5 · Cited by 14
Modelling the innate immune system in microphysiological systems
Rupar, M. J., Hanson, H. M., Rogers, S., Botlick, B. L., Trimmer, S. J., & Hickman, J. J. (2024) · Lab on a Chip · doi:10.1039/d3lc00812f · Cited by 15
Proteomics profiling of inflammatory responses to elexacaftor/tezacaftor/ivacaftor in cystic fibrosis
Ozuna, H., Bojja, D., Partida‐Sánchez, S., Hall‐Stoodley, L., Amer, A. O., Britt, R. D., Sheikh, S. I., Frank, D. A., Wang, W., Kang, B., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1486784 · Cited by 13
Increased prevalence and altered species composition of filamentous fungi in respiratory specimens from cystic fibrosis patients
Nielsen, S. M., Kristensen, L., Søndergaard, A., Handberg, K. J., Stenderup, J., & Nørskov‐Lauritsen, N. (2014) · Apmis · doi:10.1111/apm.12253 · Cited by 16
Contributing Factors to the Clinical and Economic Burden of Patients with Laboratory-Confirmed Carbapenem-Nonsusceptible Gram-Negative Respiratory Infections
McCann, E., Sung, A., Ye, G., Vankeepuram, L., & Tabak, Y. P. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s236026 · Cited by 13
The Sense and Nonsense of Antimicrobial Susceptibility Testing in Cystic Fibrosis
LiPuma, J. J. (2022) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piac040 · Cited by 13
Self-citation
Impact of storage conditions on metabolite profiles of sputum samples from persons with cystic fibrosis
Zhao, J., Evans, C. R., Carmody, L. A., & LiPuma, J. J. (2015) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2015.02.004 · Cited by 13
Self-citation
Drug interactions and treatment burden as survival improves
Nichols, D. P., Kuk, K. N., & Nick, J. A. (2015) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000212 · Cited by 13
Developing a model for cystic fibrosis sociomicrobiology based on antibiotic and environmental stress
Lopes, S. P., Azevedo, N. F., & Pereira, M. O. (2017) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2017.09.018 · Cited by 13
Antimicrobial Stewardship in Cystic Fibrosis
Lloyd, E. C., Cogen, J. D., Maples, H. D., Bell, S. C., & Saiman, L. M. (2022) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piac071 · Cited by 12
An in vitro model for the cultivation of polymicrobial biofilms under continuous-flow conditions
O’Brien, T. J., Hassan, M. M., Harrison, F., & Welch, M. (2021) · F1000Research · doi:10.12688/f1000research.55140.1 · Cited by 13
Therapeutic beta-lactam dosages and broad-spectrum antibiotics are associated with reductions in microbial richness and diversity in persons with cystic fibrosis
Hahn, A., Burrell, A., Chaney, H. R., Sami, I. R., Koumbourlis, A. C., Freishtat, R. J., Crandall, K. A., & Zemanick, E. T. (2023) · Scientific Reports · doi:10.1038/s41598-023-27628-x · Cited by 12
Pseudomonas aeruginosa Host Immune Evasion
Cohen, T. S., Parker, D., & Prince, A. S. (2014) · Springer eBooks · doi:10.1007/978-94-017-9555-5_1 · Cited by 12
The contribution of respiratory microbiome analysis to a treatable traits model of care
Taylor, S., O’Farrell, H. E., Simpson, J. L., Yang, I. A., & Rogers, G. B. (2018) · Respirology · doi:10.1111/resp.13411 · Cited by 11
Loci Encoding Compounds Potentially Active against Drug-Resistant Pathogens amidst a Decreasing Pool of Novel Antibiotics
Basalla, J. L., Chatterjee, P., Burgess, E., Khan, M., Verbrugge, E., Wiegmann, D. D., LiPuma, J. J., & Wildschutte, H. (2019) · Applied and Environmental Microbiology · doi:10.1128/aem.01438-19 · Cited by 11
Self-citation
Proteomic interrogation of antibiotic resistance and persistence inEscherichia coli –progress and potential for medical research
Zhang, D., Hu, Y., Zhu, Q., Huang, J., & Chen, Y. (2020) · Expert Review of Proteomics · doi:10.1080/14789450.2020.1784731 · Cited by 11
Microbial Communities of Conducting and Respiratory Zones of Lung-Transplanted Patients
Beaume, M. G., Lazarević, V., Köhler, T., Gaïa, N., Manuel, O., Aubert, J., Bærlocher, L., Farinelli, L., Soccal, P. M., Schrenzel, J., et al. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01749 · Cited by 14
Composition of airway bacterial community correlates with chest HRCT in adults with bronchiectasis
O’Neill, K., Einarsson, G. G., Rowan, S., McIlreavey, L., Lee, A. J., Lawson, J., Lynch, T. B., Horsley, A. R., Bradley, J. M., Elborn, J. S., et al. (2019) · Respirology · doi:10.1111/resp.13653 · Cited by 11
Le microbiome pulmonaire en 2015
Andréjak, C., & Delhaès, L. (2015) · médecine/sciences · doi:10.1051/medsci/20153111011 · Cited by 12
The Human Microbiome
Meisel, J. S., & Grice, E. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800681-8.00004-9 · Cited by 12
Expanding Our Understanding of Respiratory Microbiota in Cystic Fibrosis
LiPuma, J. J. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201407-303ed · Cited by 11
Self-citation
In host evolution of Exophiala dermatitidis in cystic fibrosis lung micro-environment
Kurbessoian, T., Murante, D., Crocker, A. W., Hogan, D. A., & Stajich, J. (2023) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkad126 · Cited by 11

Authors: Zhao, J., Schloss, P. D., Kalikin, L. M., Carmody, L. A., Foster, B. K., Petrosino, J. F., Cavalcoli, J. D., VanDevanter, D. R., Murray, S., Li, J. Z., Young, V. B., & LiPuma, J. J.
Affiliations: University of Michigan (US)
Microbiology and Immunology,
Baylor College of Medicine (US)
Case Western Reserve University (US)
Biostatistics and
Human Genetics, and
ORCID: Zhao, Jiangchao
Schloss, Patrick D.
Carmody, Lisa A.
Petrosino, Joseph F.
VanDevanter, Donald R.
Murray, Susan
Li, Jun Z.
Young, Vincent B.
LiPuma, John J.
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 2012-03-26
Volume: 109
Issue: 15
Pages: 5809-5814
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.1120577109
PMC: PMC3326496
OpenAlex: W2094167812
Cited by: 599
References: 18
Citations by year: 2026: 12 · 2025: 18 · 2024: 32 · 2023: 31 · 2022: 37 · 2021: 41 · 2020: 57 · 2019: 57 · 2018: 40 · 2017: 39 · 2016: 50 · 2015: 61 · 2014: 63 · 2013: 43 · 2012: 18
FWCI: 47.73
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Deep Blue (University of Michigan) (submittedVersion)
Funders: National Institutes of Health (5rc1hl100809-02)
National Heart, Lung, and Blood Institute (U01HL098961, RC1-HL100809, 1RC1HL100809-01)
National Human Genome Research Institute (R01HG005975, R01HG004906)
National Institute of Diabetes and Digestive and Kidney Diseases (P30DK034933, P30DK027651)
National Center for Research Resources (UL1RR024986)
Topics: Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
Physical Sciences › Environmental Science › Ecology › Microbial Community Ecology and Physiology
Keywords: cystic fibrosis, sputum microbiome, bacterial diversity, antibiotic therapy, community resilience, pulmonary exacerbations, disease progression, 16S rRNA gene sequencing, interpatient variability
MeSH terms: Adolescent, Adult, Aging, Anti-Bacterial Agents, Bacteria, Cystic Fibrosis, Humans, Lung, Male, Respiratory Function Tests, Sputum, Disease Progression, Principal Component Analysis, Biodiversity, Metagenome, Young Adult, Bacterial Load

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Decade-long bacterial community dynamics in cystic fibrosis airways

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks